Merck
RECARBRIO
Manufacturer:
Merck
Name:
RECARBRIO
HCPCS Code Descriptor:
Injection, imipenem 4 mg, cilastatin 4 mg and relebactam 2 mg
Category:
J Code
HCPCS:
J0742
NDC(s):
00006-3856-02
Primary Type:
Antibiotic
Generic/Specialty Status:
Single-Source
Route of Administration:
Intravenous
Potential NDC Listing Errors:
Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.
About:
RECARBRIO is an Antibiotic drug manufactured by Merck and administered via the Intravenous route of administration. The J Code: J0742 is aligned to the drug RECARBRIO.
Access Pricing and More By Registering
HCPCS Added Date:
7/1/20
HCPCS Effective Date:
7/1/20
HCPCS Short Description:
Inj imip 4 cilas 4 releb 2mg
Billing and Coding Guide:
https://www.merckconnect.com/static/pdf/recarbrio-dosing-and-billing-guide.pdf
Patient Assistance:
https://www.merckhelps.com/
